Correspondence| Volume 21, ISSUE 12, P1229-1230, October 1986

Hydergine effect on prolactin and reaction time in dementia

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Psychiatric Association
        3rd ed. Diagnostic and Statistical Manual. American Psychiatric Association, Washington, DC1980
        • Besses GS
        • Burrow GN
        • Spaulding SW
        • Donabedian RK
        Dopamine infusion acutely inhibits the TSH and prolactin response to TRH.
        J Clin Endocrinol Metab. 1975; 41: 985-988
        • Ermini M
        • Markstein R
        Hydergine therapy: Mechanism of action.
        in: Br J Clin Pract Symposium Suppl. 1981: 27-32
        • Gottfries CG
        Etiological and treatment considerations in SDAT.
        in: Crook T Gershon S Strategies for the Development of an Effective Treatment for Senile Dementia. Marc Powley Associates, 1981: 107-123
        • Hindmarch I
        • Parrott AC
        • Lanza M
        The effects of an ergot alkaloid derivative (hydergine) on aspects of psychomotor performance, arousal and cognitive processing ability.
        J Clin Pharmacol. 1979; 19: 726-730
        • Hoffman M
        • Tonon GC
        • Spano PF
        • Trabucchi M
        Mechanism of dihydroergotoxine's effect on prolactin release.
        J Pharm Pharmacol. 1979; 31: 42-44
        • Lancet Editorial
        Ergot for dementia?. 1984; ii: 1313-1314
        • Loew DM
        • Vigouret JM
        • Jaton A
        Neuropharma cology of bromcriptine and dihydroergotoxine (hydergine).
        in: Goldsten M Ergot Compounds and Brain Function. Raven Press, New York1980: 63-75
        • Pattie AH
        • Grilleard CJ
        The Clifton Assessmenl Schedule—Further validation of a psychogeriatric as sessment schedule.
        Br J Psychiatry. 1976; 129: 68-72
        • Vigouret JM
        • Burki HR
        • Jaton AL
        • Qugor PE
        • Loew DM
        Neurochemical and neuropharmacological investigations with four ergot derivatives: Bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.
        Pharmacology. 1978; 16: 156-173